Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Search Inside the pdf :

Lasa Supergenerics Ltd.

13 Aug 2025

9.75

-2.89%

Company Update

Lasa Supergenerics Ltd - 540702 - Integrated Filing June 2025

BSE India

Integrated filing June 2025

pdf

Lasa Supergenerics Ltd.

13 Aug 2025

9.75

-2.89%

Result

Lasa Supergenerics Ltd - 540702 - Financial Results As On June 30, 2025

BSE India

Financials results as on June 30, 2025

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	20.15	41.53	30.84	-51.5%	-34.7%
Operating Profit Qtr	-0.50	3.41	1.80	-114.7%	-127.8%
Net Profit Qtr	-21.12	-14.29	-2.73	-47.8%	-673.6%
Earning Per Share Adjusted latest Qtr	-4.22	-2.85	-0.55	-48.1%	-667.3%

* Standalone data

Detailed Results

Lasa Supergenerics Ltd.

13 Aug 2025

9.75

-2.89%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 05.00 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended June 30, 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on June 30, 2025.

pdf

Lasa Supergenerics Ltd.

05 Aug 2025

9.75

-2.89%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for The Quarter Ended June 30, 2025

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 13, 2025, inter alia; 1. To consider, approve and take on records Unaudited financial results of the Company for the quarter ended June 30, 2025. 2. To discuss any other matter with the permission of the Chairperson. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter ended June 30, 2025.

pdf

Lasa Supergenerics Ltd.

05 Aug 2025

9.75

-2.89%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Pursuant to reg 30 SEBI (LODR) Regulations, 2015, we wolud like ti inform you about Board of Directors Meeting held today, 05th August, 2025 at 3.00 PM to 4.30 PM considered and approve the appointment of Independent Directors.

pdf

Lasa Supergenerics Ltd.

05 Aug 2025

9.75

-2.89%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 3.00 P.M. and concluded at 4.30 P.M. inter- alia have considered and approved the following: Appointment of the following individuals as an Additional Director (Non-Executive Independent Director) of the Company and he shall be designated as Independent Director of the Company each for a term of 5 (five) years with effect from August 05, 2025, subject to the approval of shareholders at General Meeting or Postal Ballot of the Company. 1. Mr. Ketan Bhau Songal (DIN: 11228418 ) 2. Mr. Pravin Gadalya Lachake (DIN: 11228417) 3. Mr. Yogesh Hari Ughada (DIN: 11230183) 4. Mrs. Rekha Hemant Wakh - Woman Director (DIN: 11229667)

pdf

Lasa Supergenerics Ltd.

04 Aug 2025

9.75

-2.89%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

With the reference to above and in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby inform you that Mr. Ajay Sukhwani and Ms Ekta Gurnasinghani, Independent Director of the Company has tendered their resignation w.e.f from 4th August, 2025

pdf

Lasa Supergenerics Ltd.

01 Aug 2025

9.75

-2.89%

AGM

Lasa Supergenerics Ltd - 540702 - Notice Of Postal Ballot, Seeking Shareholders' Approval For Appointment Of …

BSE India

Pursuant to Reg 30 SEBI (LODR) regulation, 2015 we enclose herewith postal ballot Notice , seeking approval of Members of the Company for below mentioned ordinary resolution

pdf

Lasa Supergenerics Ltd.

01 Aug 2025

9.75

-2.89%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

With the reference to disclosure submitted on dated 31.07.2025, we hereby submit the revised Disclosure.

pdf

Lasa Supergenerics Ltd.

01 Aug 2025

9.75

-2.89%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

With the reference to the above anf compliance with Reg 30 of SEBI (LODR) Regulations 2015, We hereby inform you that Mr. Hardesh Tolani , independent Director of the Company tender his resignation w.e.f from July 31, 2025

pdf

Is Lasa Supergenerics Ltd. worth buying?

52 Votes:

Buy 76.92%

Sell 17.31%

Hold 5.77%